Défoncé Chocolatier is Elevating Edibles

In episode 54 of Investing in Cannabis, Brandon David interviews Eric Eslao, CEO of Défoncé Chocolatier, touring the company’s new 10K sq. ft. facility in Oakland and learning more about one...
- December 10th, 2016 at 9:28 am

Maryland Names Medical Cannabis Dispensary License Pre-Approvals

Maryland Medical Cannabis Commission Announces 102 Dispensary License Pre-Approvals Baltimore, MD (December 9, 2016) – The Maryland Medical Cannabis Commission (“MMCC”) today announced the names of 102 Dispensary entities who have...
- December 9th, 2016 at 5:24 pm

NCIA to Present Cannabis Industry Awards

The National Cannabis Industry Association (NCIA) will be presenting awards in several categories to its members at the Seed to Sale Show taking place in Denver on January 31st...
- December 9th, 2016 at 12:07 pm

Emblem to Begin Trading on the TSX Venture

Emblem Corp. Goes Public under Symbol EMC.V TORONTO, ONTARIO–(Marketwired – Dec. 8, 2016) – After much anticipation from the North American investment community, Emblem Corp. (TSXV: EMC) is set...
- December 8th, 2016 at 3:02 pm

Cannabis Grow System Maker LEAF Raises $2mm

LEAF Launches Plug-N-Plant Smart Home Cannabis Growing System, Allowing Users to Automate Growing Their Own Medical Marijuana Startup Raised $2 Million in Seed Funding to Allow Users to Grow...
- December 7th, 2016 at 9:56 am

Aurora Cannabis CEO Projects Profitability at Hand

Aurora Cannabis (TSXV: ACB) (OTC: ACBFF) CEO Terry Booth was interviewed Friday by Andrew Bell of BNN, who began with a question about the company’s financials.  Booth stated that...
- December 6th, 2016 at 7:39 pm

iAnthus Acquires Assets of Organix in Breckenridge, Colorado

iAnthus Closes Its First Cannabis-Related Asset Acquisition in Colorado TORONTO, ON and NEW YORK, NY — (Marketwired) — 12/05/16 — iAnthus Capital Holdings, Inc., (CSE: IAN) (OTC: ITHUF) (“Company”), announced...
- December 5th, 2016 at 9:29 pm

GW Pharma Ends FY16 with $483mm in Cash

GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2016 Financial Results and Operational Progress – Three Positive Phase 3 Epidiolex clinical trials reported in 2016 – – NDA submission...
- December 5th, 2016 at 7:52 am

GW Pharma Progresses Towards Epidiolex FDA Submission

GW Announces New Epidiolex® (CBD) Positive Phase 3 Data in Dravet Syndrome and Lennox-Gastaut Syndrome – Posters Presented at American Epilepsy Society Annual Meeting – – New data includes...
- December 5th, 2016 at 7:39 am

Canopy Growth Forms Cannabis Research Incubator

Canopy Growth (TSX: CGC) (OTC: TWMJF) unveiled a new initiative today, Canopy Health Innovations (CHI), a cannabis research incubator that it formed in August. CHI will conduct exploratory studies...
- December 2nd, 2016 at 12:09 pm